1. Home
  2. SCLX vs PBK Comparison

SCLX vs PBK Comparison

Compare SCLX & PBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Scilex Holding Company

SCLX

Scilex Holding Company

N/A

Current Price

$2.06

Market Cap

27.9M

Sector

Health Care

ML Signal

N/A

Logo PowerBank Corporation Common Stock

PBK

PowerBank Corporation Common Stock

N/A

Current Price

$0.15

Market Cap

24.3M

Sector

Utilities

ML Signal

N/A

Company Overview

Basic Information
Metric
SCLX
PBK
Founded
2011
2013
Country
United States
Canada
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Power Generation
Sector
Health Care
Utilities
Exchange
Nasdaq
Nasdaq
Market Cap
27.9M
24.3M
IPO Year
2020
2024

Fundamental Metrics

Financial Performance
Metric
SCLX
PBK
Price
$2.06
$0.15
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
★ $4.00
AVG Volume (30 Days)
40.4K
★ 645.6K
Earning Date
11-13-2026
11-16-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $30,253,000.00
N/A
Revenue This Year
$118.16
$171.32
Revenue Next Year
$186.31
$40.20
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$2.27
$0.17
52 Week High
$27.00
$0.86

Technical Indicators

Market Signals
Indicator
SCLX
PBK
Relative Strength Index (RSI) 14.46 24.62
Support Level N/A N/A
Resistance Level $7.77 $0.29
Average True Range (ATR) 0.23 0.02
MACD -0.01 0.00
Stochastic Oscillator 2.53 10.49

Price Performance

Historical Comparison
SCLX
PBK

About SCLX Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain. It targets indications with high unmet needs and large market opportunities with non-opioid therapies for the treatment of patients with acute and chronic pain and are dedicated to advancing and improving patient outcomes. Its commercial products are: ZTlidoO for the relief of neuropathic pain associated with postherpetic neuralgia (PHN), which is a form of post-shingles nerve pain; ELYXYB, a potential first-line treatment ready-to-use oral solution for the acute treatment of migraine in adults and GLOPERBA, the liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults.

About PBK PowerBank Corporation Common Stock

PowerBank Corp is an independent renewable and clean energy project developer, power producer, and asset operator in Canada and the United States, with the majority of its revenue coming from the United States. The Company operates through two reportable segments: Development and EPC, which involves the development and construction of solar photovoltaic power projects, and IPP Production, which includes the operation of solar power and battery energy storage systems. Corporate and other activities cover operation, maintenance, and repairs. The majority of revenue is generated from the Development and EPC segment.

Share on Social Networks: